Cellular Immunotherapy Market 2024-2033 | Size, Share And Insights

The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033.

The Cellular Immunotherapy market has experienced rapid growth, ascending from $4.99 billion in 2023 to a projected $5.78 billion in 2024, at a remarkable Compound Annual Growth Rate (CAGR) of 15.9%. This robust growth trend is anticipated to persist, with the cellular immunotherapy market reaching $9.95 billion by 2028, boasting a CAGR of 14.6%.

Drivers of Market Growth:
1. Research and Clinical Advances as Catalysts:
The proliferation of research initiatives and successful clinical trials in cellular immunotherapy is a pivotal driver for market expansion. Focused efforts by companies to develop novel cellular immunotherapies for diverse diseases, exemplified by a significant increase in active cell therapy drugs, are propelling market growth. In 2022, there were 2,756 active cell therapy drugs, signifying a 36% increase from the previous year. The rapid development in clinical and preclinical stages is expected to generate substantial revenue, fostering the growth of the cellular immunotherapy market.

2. Addressing the Rising Prevalence of Cancer:
The escalating prevalence of cancer is a key factor propelling the cellular immunotherapies market. Cancer's widespread impact has prompted extensive research and investment in innovative therapies, including cellular immunotherapies. These therapies leverage the body's immune system to combat cancer cells, involving the extraction, amplification, and reintroduction of immune cells. The rising cancer incidence, with estimated new cases and deaths in 2021 surpassing 1.9 million and 608,570, respectively, underscores the pivotal role of cellular immunotherapies in addressing the global cancer burden.

Explore the Global Cellular Immunotherapy Market with a Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3435&type=smp

Market Players and Industry Landscape:

Major companies at the forefront of the Cellular Immunotherapy market include Novartis International AG, Gilead Sciences Inc., Apac Biotech, Dendreon Pharmaceuticals LLC, JW CreaGene Co. Ltd., Green Cross Corp, AstraZeneca PLC, Bristol Myers Squibb Company, Pfizer Inc., F. Hoffmann-La Roche Ltd., and numerous others. These entities play a critical role in developing and providing cutting-edge solutions, contributing to the dynamic landscape of the cellular immunotherapy market.

Technological Advancements in Cellular Immunotherapy:

1. Rise of Off-The-Shelf Allogeneic Therapies:
Companies are strategically focusing on the development of off-the-shelf allogeneic therapies, presenting a paradigm shift in cancer treatment. Unlike autologous therapy, these therapies are derived from donor cells, offering advantages such as cost-effectiveness, scalability, rapid production, and enhanced quality control. Novartis AG, for instance, received expedited FDA approval for Kymriah, an off-the-shelf allogeneic therapy, indicating the industry's commitment to advancing treatment options.

2. Emergence of the T-Charge Platform:

The introduction of innovative technologies, such as the T-Charge platform, is shaping the future of cellular immunotherapy. Novartis unveiled the T-Charge platform in December 2021, maintaining the stemness, self-renewal, and maturation capabilities of T cells. This innovation results in a product with heightened proliferative capacity, fewer tired T cells, and a higher likelihood of stronger and more persistent responses. The T-Charge platform exemplifies the ongoing advancements driving the evolution of cellular immunotherapy.

Geographical Landscape and Market Segmentation:

In 2023, North America claimed the largest share in the Cellular Immunotherapy market. The comprehensive market segmentation encompasses regions like Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, and Africa.

The cellular immunotherapy market covered in this report is segmented -

1) By Therapy: Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy
2) By Primary Indication: B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications
3) By Application: Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications

Access the Complete Report for In-Depth Analysis:
https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

Cellular Immunotherapy Global Market Report 2024 from TBRC covers the following information:

Market size date for the forecast period: Historical and Future
Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.

The Cellular Immunotherapy Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on cellular immunotherapy market size, cellular immunotherapy market drivers and trends, cellular immunotherapy market major players, cellular immunotherapy market competitors' revenues, cellular immunotherapy market positioning, and cellular immunotherapy market growth across geographies. The cellular immunotherapy market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the cellular immunotherapy market report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Immunochemistry Diagnostic Devices And Equipment Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/immunochemistry-diagnostic-devices-and-equipment-global-market-report

Drugs For Immunotherapy Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Immunodiagnostics Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company has published over 3000+ detailed industry reports, spanning over 6500+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model - Market Intelligence Database
The Global Market Model, The Business Research Company's flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

This release was published on openPR.